Cargando…

Editorial: Dual role of inflammatory mediators in cancer immunotherapy

Detalles Bibliográficos
Autores principales:	Wang, Xiaoli, He, Jiashuai, Pan, Jinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425530/ https://www.ncbi.nlm.nih.gov/pubmed/37588596 http://dx.doi.org/10.3389/fimmu.2023.1229355

Ejemplares similares

Editorial: Novel biomarkers for predicting response to cancer immunotherapy
por: Huangfu, Shuchen, et al.
Publicado: (2023)

Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
por: Lafont, Virginie, et al.
Publicado: (2021)

Editorial: Translation of genetically engineered T cells in cancer immunotherapy
por: Voss, Ralf-Holger, et al.
Publicado: (2023)

Editorial: “Cancer Immunotherapy: Lights and Shadows”
por: Barrio, María Marcela, et al.
Publicado: (2015)

Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Editorial: Immune Outposts on the Inflammatory Frontier: Tertiary Lymphoid Structures as Targets for Immunotherapy of Cancer and Autoimmunity
por: Silina, Karina, et al.
Publicado: (2019)

Editorial: Nanobody-based cancer immunotherapy and immunoimaging
por: Jafari, Mahdie, et al.
Publicado: (2023)

Editorial: Extracellular traps in cancer immunity and immunotherapy
por: Rahat, Michal A., et al.
Publicado: (2023)

Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Editorial: CD4(+) T Cells in Cancer Immunotherapies
por: González-Navajas, José M., et al.
Publicado: (2021)

Editorial: The role of multi-omics variants in tumor immunity and immunotherapy
por: Chen, Shuang, et al.
Publicado: (2022)

Editorial: Role of Neutrophils in Inflammatory Diseases
por: Marichal, Thomas, et al.
Publicado: (2020)

Editorial: Role of Macrophage MicroRNAs in Inflammatory Diseases and Cancer
por: Renaudineau, Yves, et al.
Publicado: (2021)

Editorial: Immunotherapy in Multiple Myeloma
por: Giuliani, Nicola, et al.
Publicado: (2019)

Editorial: Targeting glucose metabolism in cancer immunity and immunotherapy
por: Feron, Olivier, et al.
Publicado: (2023)

Editorial: Emerging talents in cancer immunity and immunotherapy: 2022
por: Maeurer, Markus
Publicado: (2023)

Editorial: Rising stars in cancer immunity and immunotherapy 2022
por: Goyvaerts, Cleo, et al.
Publicado: (2023)

Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms
por: Chandra, Janin, et al.
Publicado: (2022)

Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
por: Martin, Francisco, et al.
Publicado: (2022)

Editorial: Extracellular Vesicles as Immunomodulatory Mediators in Inflammatory Processes
por: Donate, Paula Barbim, et al.
Publicado: (2022)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
por: von Knethen, Andreas, et al.
Publicado: (2021)

Editorial: Role of stem cell derivatives in inflammatory diseases
por: Zhang, Cuiping, et al.
Publicado: (2023)

Editorial: Role of matrix metalloproteinases and other inflammatory mediators in the disruption of the intestinal tight junction barrier
por: Al-Sadi, Rana, et al.
Publicado: (2023)

Editorial: Screening and verification of new targets for CAR-T immunotherapy in cancer
por: Su, Yang, et al.
Publicado: (2023)

Editorial: Non-coding RNA in improving the efficacy of cancer immunotherapy
por: Dong, Peixin, et al.
Publicado: (2023)

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies
por: Nan, Yanyang, et al.
Publicado: (2023)

Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics
por: Khan, Mohd Wajid Ali, et al.
Publicado: (2023)

Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
por: Hoden, Bettina, et al.
Publicado: (2023)

Editorial: HIV and Cancer Immunotherapy: Similar Challenges and Converging Approaches
por: Paiardini, Mirko, et al.
Publicado: (2020)

Editorial: Post-translational modifications of proteins in cancer immunity and immunotherapy
por: Dai, Xiangpeng, et al.
Publicado: (2022)

Editorial: Influenza Virus Vaccines and Immunotherapies
por: Kumar, Arun, et al.
Publicado: (2015)

Tumor neoantigens: Novel strategies for application of cancer immunotherapy
por: GUAN, HANYANG, et al.
Publicado: (2023)

T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy
por: Gao, Zhanyan, et al.
Publicado: (2022)

Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies
por: Shi, Tao, et al.
Publicado: (2023)

Editorial: Innate Immune Cells and Inflammatory Mediators in Mucosal Pathologies
por: Maria, Leite-de-Moraes, et al.
Publicado: (2020)

Editorial: Immunomodulatory role of metalloproteases in chronic inflammatory diseases
por: Yang, Guan-Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_adsai1rb24qevvqu5tjakqku68